Dubbed Cambridge Crossing, Sanofi’s new U.S. facilities set to open during May 2022 will hold the tools to develop innovative drug discovery platforms for chemistry, protein engineering, structural and synthetic biology, among many other key modalities.

USRetina, the nation’s largest independent provider of technology and services specific to retina practices, announced the launch of a new corporate brand identity and tagline.